FHIR Cross-Version Extensions package for FHIR R4 from FHIR R5
0.0.1-snapshot-2 - informative International flag

FHIR Cross-Version Extensions package for FHIR R4 from FHIR R5 - Version 0.0.1-snapshot-2. See the Directory of published versions

ValueSet: Cross-version VS for R5.MedicationGeneralizationRoleType for use in FHIR R4

Official URL: http://hl7.org/fhir/5.0/ValueSet/R5-v3-MedicationGeneralizationRoleType-for-R4 Version: 0.0.1-snapshot-2
Standards status: Informative Maturity Level: 0 Computable Name: R5_v3_MedicationGeneralizationRoleType_for_R4

This cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v3-MedicationGeneralizationRoleType 2.0.0 for use in FHIR R4. Concepts not present here have direct equivalent mappings crossing all versions from R5 to R4.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://terminology.hl7.org/CodeSystem/v3-RoleCode version 2.2.0
    CodeDisplayDefinition
    DCtherapeutic class**Description:**A categorization of medicinal products by their therapeutic properties and/or main therapeutic use.
    GDgeneric drugRelates a manufactured drug product to the non-proprietary (generic) representation of its ingredients independent of strength, and form.

    The scoping entity identifies a unique combination of medicine ingredients; sometimes referred to as "ingredient set".
    GDFgeneric drug formRelates a manufactured drug product to the non-proprietary (generic) representation of its ingredients and dose form, independent of strength of the ingredients. The scoping entity identifies a unique combination of medicine ingredients in a specific dose form.
    GDSgeneric drug strengthRelates a manufactured drug product to the non-proprietary (generic) representation of is ingredients with their strength. The scoping entity identifies a unique combination of medicine ingredients with their strength.
    GDSFgeneric drug strength formRelates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form.
    MGDSFmanufactured drug strength formRelates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form.

 

Expansion

This value set expansion contains 6 concepts.

CodeSystemDisplayDefinition
  DChttp://terminology.hl7.org/CodeSystem/v3-RoleCodetherapeutic class

**Description:**A categorization of medicinal products by their therapeutic properties and/or main therapeutic use.

  GDhttp://terminology.hl7.org/CodeSystem/v3-RoleCodegeneric drug

Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients independent of strength, and form.

The scoping entity identifies a unique combination of medicine ingredients; sometimes referred to as "ingredient set".

  GDFhttp://terminology.hl7.org/CodeSystem/v3-RoleCodegeneric drug form

Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients and dose form, independent of strength of the ingredients. The scoping entity identifies a unique combination of medicine ingredients in a specific dose form.

  GDShttp://terminology.hl7.org/CodeSystem/v3-RoleCodegeneric drug strength

Relates a manufactured drug product to the non-proprietary (generic) representation of is ingredients with their strength. The scoping entity identifies a unique combination of medicine ingredients with their strength.

  GDSFhttp://terminology.hl7.org/CodeSystem/v3-RoleCodegeneric drug strength form

Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form.

  MGDSFhttp://terminology.hl7.org/CodeSystem/v3-RoleCodemanufactured drug strength form

Relates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form.

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code